Surgical Procedures After Neoadjuvant Chemotherapy in Operable Breast Cancer: Results of the GEPARDUO Trial

被引：0
|
作者：
Sibylle Loibl
Gunter von Minckwitz
Günther Raab
Jens-Uwe Blohmer
Serban Dan Costa
Bernd Gerber
Holger Eidtmann
Simone Petrich
Jörn Hilfrich
Christian Jackisch
Andreas du Bois
Manfred Kaufmann
机构：
[1] J. W. Goethe University,Department of Obstetrics and Gynecology
[2] German Breast Group,Department of Obstetrics and Gynecology
[3] Praxis,Department of Obstetrics and Gynecology
[4] St. Gertrauden Krankenhaus,Department of Obstetrics and Gynecology
[5] Otto-von-Guericke-University,undefined
[6] Klinikum Süd,undefined
[7] Christian-Albrecht-University,undefined
[8] Henriettenstiftung,undefined
[9] Klinikum Offenbach,undefined
[10] HSK,undefined
[11] Dr. Horst Schmidt Klinik,undefined
[12] Wolfartklinik,undefined
来源：
Annals of Surgical Oncology | 2006年 / 13卷
关键词：
Neoadjuvant therapy; Breast cancer; Breast conservation; Surgery; Re-excision;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1434 / 1442
页数：8
相关论文
共 50 条
  • [21] Economic evaluation of neoadjuvant chemotherapy for operable breast cancer.
    Zdenkowski, Nicholas
    D'Silva, Shefi Mary
    Lawson, Kenny
    Reeves, Penny
    Boyle, Frances M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Neoadjuvant chemotherapy in operable breast cancer: effect on tumoral diameter
    Ruiz, C
    Barros, RA
    Nisida, A
    Rezende, W
    Pinotti, J
    BREAST, 1997, 6 (05): : P948 - P948
  • [23] PRIMARY MEDICAL (NEOADJUVANT) CHEMOTHERAPY FOR OPERABLE BREAST-CANCER
    SMITH, IE
    JONES, AL
    OBRIEN, MER
    MCKINNA, JA
    SACKS, N
    BAUM, M
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (12) : 1796 - 1799
  • [24] PRIMARY MEDICAL (NEOADJUVANT) CHEMOTHERAPY FOR OPERABLE BREAST-CANCER
    SMITH, IE
    JONES, AL
    OBRIEN, MER
    MCKINNA, JA
    SACKS, N
    BAUM, M
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (04) : 592 - 595
  • [25] Comparison of 3 neoadjuvant chemotherapy regimens for operable breast cancer
    vanPraggh, I
    Ferriere, JP
    Cure, H
    Feillel, V
    LeBouedec, G
    deLatour, M
    Rolhion, C
    Charrier, S
    Assier, I
    Misset, JL
    Dauplat, J
    Chollet, P
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 53 - 53
  • [26] Phase II trial combining docetaxel and doxorubicin as neoadjuvant chemotherapy in patients with operable breast cancer
    Ganem, G
    Tubiana-Hulin, M
    Fumoleau, P
    Combe, M
    Misset, JL
    Vannetzel, JM
    Bachelot, T
    De Ybarlucea, LR
    Lotz, V
    Bendahmane, B
    Dieras, V
    ANNALS OF ONCOLOGY, 2003, 14 (11) : 1623 - 1628
  • [27] Indications, contra-indications, expected results and choice of neoadjuvant chemotherapy for operable breast cancer
    Mouret-Reynier, Marie-Ange
    Abrial, Catherine
    Leheurteur, Marianne
    Durando, Xavier
    Van Praagh, Isabelle
    Gimbergues, Pierre
    Achard, Jean-Louis
    Ferriere, Jean-Pierre
    Cure, Herve
    Chollet, Philippe
    BULLETIN DU CANCER, 2006, 93 (11) : 1121 - 1129
  • [28] Breast and axillary downstaging after neoadjuvant chemotherapy in breast cancer: surgical technique
    D'Alonzo, M.
    Minella, C.
    Villasco, A.
    Accomasso, F.
    Biglia, N.
    BREAST, 2021, 56 : S51 - S51
  • [29] Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma
    Kuerer, HM
    Singletary, SE
    Buzdar, AU
    Ames, FC
    Valero, V
    Buchholz, TA
    Ross, MI
    Pusztai, L
    Hortobagyi, GN
    Hunt, KK
    AMERICAN JOURNAL OF SURGERY, 2001, 182 (06): : 601 - 608
  • [30] Pathological workup of surgical breast cancer specimens after neoadjuvant chemotherapy
    Denkert, Carsten
    BREAST CARE, 2006, 1 (06) : 368 - 373
12345